documents: FDA-2025-N-2787-0007

Federal regulatory documents currently open for public comment. ⚠ Derive comment deadlines from comment_end_datetime converted to America/New_York, never from comment_end_date, which is mid-correction and may be one day late (DataDawn queue #498).

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	agency_id	docket_id	title	document_type	subtype	posted_date	posted_year	posted_month	comment_start_date	comment_end_date	comment_end_datetime	perpetual_docket	last_modified	fr_doc_num	open_for_comment	withdrawn	object_id
FDA-2025-N-2787-0007	FDA	FDA-2025-N-2787	Biosimilar User Fee Act III Future Needs in the Development of Interchangeable Products Post-Workshop; Draft Strategy Document	Notice	Notice of Availability	2026-09-18	2026	9	2026-09-18	2026-11-17	2026-11-18 04:59:59	0	2026-09-18 18:37:52	2026-19166	1	0	09000064b958ecea